RANKL acts directly on RANK-expressing tumour cells to induce actin polymerization and increase cell migration.15 In a mouse model of bone metastasis using B16F10 cells that do not trigger osteoclast activation, an OPG treatment markedly reduced the tumour burden in the bones, whereas treatment with bisphosphonate had no effect. This evidence concerns the gene TNFSF11 and neoplasm.